EA200100697A1 - Способ получения n6-замещенных производных деаза-аденозина - Google Patents

Способ получения n6-замещенных производных деаза-аденозина

Info

Publication number
EA200100697A1
EA200100697A1 EA200100697A EA200100697A EA200100697A1 EA 200100697 A1 EA200100697 A1 EA 200100697A1 EA 200100697 A EA200100697 A EA 200100697A EA 200100697 A EA200100697 A EA 200100697A EA 200100697 A1 EA200100697 A1 EA 200100697A1
Authority
EA
Eurasian Patent Office
Prior art keywords
obtaining
adenosine derivatives
substituted
deaza
substituted deaza
Prior art date
Application number
EA200100697A
Other languages
English (en)
Other versions
EA003645B1 (ru
Inventor
Дайан К. Салазар
Уолтер Родригез
Джеймс П. Шербайн
Рик Г. Вудворд
Адам В. Следески
Мэттью Р. Пауэрс
Майкл К. О'Брайен
Original Assignee
Авентис Фармасьютикалз Продактс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Авентис Фармасьютикалз Продактс Инк. filed Critical Авентис Фармасьютикалз Продактс Инк.
Publication of EA200100697A1 publication Critical patent/EA200100697A1/ru
Publication of EA003645B1 publication Critical patent/EA003645B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Данное изобретение направлено на способы получения N6-замещенных производных аденозина, пригодные для этого промежуточные соединения и способы получения этих промежуточных соединений.Отчет о международном поиске был опубликован 2000.09.14.
EA200100697A 1998-12-21 1999-12-14 Способ получения n6-замещенных производных деаза-аденозина EA003645B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11307798P 1998-12-21 1998-12-21
PCT/US1999/029643 WO2000037469A2 (en) 1998-12-21 1999-12-14 Process for preparing n6-substituted deaza-adenosine derivatives

Publications (2)

Publication Number Publication Date
EA200100697A1 true EA200100697A1 (ru) 2001-12-24
EA003645B1 EA003645B1 (ru) 2003-08-28

Family

ID=22347487

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200100697A EA003645B1 (ru) 1998-12-21 1999-12-14 Способ получения n6-замещенных производных деаза-аденозина

Country Status (28)

Country Link
US (1) US6184382B1 (ru)
EP (1) EP1175420B1 (ru)
JP (1) JP2002533343A (ru)
KR (1) KR20010087425A (ru)
CN (1) CN1122667C (ru)
AP (1) AP1336A (ru)
AT (1) ATE235493T1 (ru)
AU (1) AU774155B2 (ru)
BG (1) BG105624A (ru)
BR (1) BR9917088A (ru)
CA (1) CA2357760A1 (ru)
CZ (1) CZ20012283A3 (ru)
DE (1) DE69906392T2 (ru)
DK (1) DK1175420T3 (ru)
EA (1) EA003645B1 (ru)
EE (1) EE200100333A (ru)
ES (1) ES2191489T3 (ru)
HK (1) HK1041607A1 (ru)
HU (1) HUP0105224A3 (ru)
ID (1) ID30118A (ru)
IL (1) IL143843A0 (ru)
NO (1) NO319789B1 (ru)
NZ (1) NZ512500A (ru)
PL (1) PL349154A1 (ru)
PT (1) PT1175420E (ru)
SK (1) SK284767B6 (ru)
WO (1) WO2000037469A2 (ru)
YU (1) YU51401A (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9713705A (pt) * 1996-12-11 2000-05-09 Rhone Poulenc Rorer Pharma Composto, e, processo para a preparação do mesmo
KR100446669B1 (ko) * 2002-04-04 2004-09-04 (주) 비엔씨바이오팜 2-(헤테로사이클릭-알킬아미노)피리딘 유도체, 그제조방법 및 이를 포함하는 항바이러스용 약학적 조성물
US7291603B2 (en) * 2002-07-24 2007-11-06 Ptc Therapeutics, Inc. Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652366A (en) * 1990-09-25 1997-07-29 Rhone-Poulenc Rorer Pharmaceuticals Inc. DI (1R)-(-)camphosulfonic acid) salt, preparation thereof and use thereof
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
WO1992005177A1 (en) * 1990-09-25 1992-04-02 Rhone-Poulenc Rorer International (Holdings) Inc. Compounds having antihypertensive and anti-ischemic properties

Also Published As

Publication number Publication date
AP1336A (en) 2004-11-30
SK9072001A3 (en) 2001-12-03
IL143843A0 (en) 2002-04-21
WO2000037469A2 (en) 2000-06-29
AU774155B2 (en) 2004-06-17
NO20013044L (no) 2001-08-20
DE69906392D1 (de) 2003-04-30
HUP0105224A3 (en) 2003-01-28
CA2357760A1 (en) 2000-06-29
ATE235493T1 (de) 2003-04-15
PT1175420E (pt) 2003-08-29
EE200100333A (et) 2002-08-15
AP2001002200A0 (en) 2001-09-30
SK284767B6 (sk) 2005-11-03
DK1175420T3 (da) 2003-07-07
NO319789B1 (no) 2005-09-12
HK1041607A1 (zh) 2002-07-12
CZ20012283A3 (cs) 2001-10-17
EP1175420A2 (en) 2002-01-30
ES2191489T3 (es) 2003-09-01
BG105624A (en) 2002-01-31
NO20013044D0 (no) 2001-06-19
WO2000037469B1 (en) 2000-11-02
PL349154A1 (en) 2002-07-01
CN1122667C (zh) 2003-10-01
ID30118A (id) 2001-11-08
NZ512500A (en) 2003-01-31
DE69906392T2 (de) 2004-02-05
EA003645B1 (ru) 2003-08-28
CN1333773A (zh) 2002-01-30
BR9917088A (pt) 2006-01-31
HUP0105224A2 (en) 2002-06-29
AU2181400A (en) 2000-07-12
US6184382B1 (en) 2001-02-06
KR20010087425A (ko) 2001-09-15
WO2000037469A3 (en) 2000-09-14
YU51401A (sh) 2003-12-31
JP2002533343A (ja) 2002-10-08
EP1175420B1 (en) 2003-03-26

Similar Documents

Publication Publication Date Title
EA200000539A1 (ru) Способ получения производных класса таксоидов
CY1105836T1 (el) 12, 13-τροποποιημενα παραγωγα εποθιλονης
EA199700061A1 (ru) Способ получения силденафила
EP1611534A4 (en) SYSTEM FOR PRODUCING SEARCH RESULTS, INCLUDING SEARCH FOR SUB-DOMAIN NOTES AND PROVIDING SPONSORED RESULTS BY SUB-DOMAIN
EA200000877A1 (ru) Система для картографирования источников акустической энергии, основанная на исследовании одной скважины
EA200100012A1 (ru) Мостиковые инденопирролокарбазолы
EA199900326A1 (ru) Промежуточные соединения и способ получения оланзапина
NO975293D0 (no) Fremgangsmåte for mottaking, samt mottaker
EA199900334A1 (ru) Циклопентеноны, способы их получения и применение
EA199800792A1 (ru) Способы получения промежуточных соединений для пестицидов
EA199800844A1 (ru) Способ получения r-альфа-пропил-пиперониламина и его аналогов, промежуточные продукты, используемые в этом способе
PT1140933E (pt) Processo para preparar derivados n6-substituidos de desaza-adenosina
DK1025083T3 (da) Fremgangsmåde til stereoselektiv syntese af prostacyclin-derivater
EA199900235A1 (ru) Аморфные бензотиофены, способы получения и способы применения
EA199900027A1 (ru) Способ получения некоторых азациклогексапептидов
EA200100697A1 (ru) Способ получения n6-замещенных производных деаза-аденозина
EA200200101A1 (ru) Получение замещенных пиперидин-4-онов
EA199900741A1 (ru) Способ получения эпросартана
EA199900740A1 (ru) Способ получения эпросартана (варианты)
EA200000069A1 (ru) Способ получения 4-замещенных-1h-индол-3-глиоксамидов
EA200100131A1 (ru) Способ получения витамина а
EA200001076A1 (ru) Способ получения 4-замещенных-1h-индол-3-глиоксамидов
EA200400876A1 (ru) Способ получения производных толуола
EA200000127A1 (ru) Способ получения аминопроизводных алкилоксифуранона, получаемые этим способом соединения и применение этих соединений
EA199900327A1 (ru) Способ получения поликапролактама

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU